Correlation Between Max Healthcare and Krebs Biochemicals

Can any of the company-specific risk be diversified away by investing in both Max Healthcare and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Max Healthcare and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Max Healthcare Institute and Krebs Biochemicals and, you can compare the effects of market volatilities on Max Healthcare and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Max Healthcare with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Max Healthcare and Krebs Biochemicals.

Diversification Opportunities for Max Healthcare and Krebs Biochemicals

0.62

Correlation Coefficient

Max Healthcare  Krebs Biochemicals

Poor diversification

The 3 months correlation between Max and Krebs is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Max Healthcare Institute and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and Max Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Max Healthcare Institute are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of Max Healthcare i.e., Max Healthcare and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between Max Healthcare and Krebs Biochemicals

Assuming the 90 days trading horizon Max Healthcare is expected to generate 1.45 times less return on investment than Krebs Biochemicals. But when comparing it to its historical volatility, Max Healthcare Institute is 2.43 times less risky than Krebs Biochemicals. It trades about 0.18 of its potential returns per unit of risk. Krebs Biochemicals and is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  7,751  in Krebs Biochemicals and on October 8, 2024 and sell it today you would earn a total of  2,240  from holding Krebs Biochemicals and or generate 28.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Max Healthcare Institute  vs.  Krebs Biochemicals and

Max Healthcare Institute

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Max Healthcare Institute are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady essential indicators, Max Healthcare disclosed solid returns over the last few months and may actually be approaching a breakup point.

Krebs Biochemicals and

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Max Healthcare and Krebs Biochemicals

The main advantage of trading using opposite Max Healthcare and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Max Healthcare position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.

The idea behind Max Healthcare Institute and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..